Tumor microenvironment activated antibodies - Shanghai Affinity Biopharmaceuticals
Alternative Names: TMEAbody; TMEAbody - Shanghai Affinity BiopharmaceuticalLatest Information Update: 12 Sep 2024
Price :
$50 *
At a glance
- Originator Shanghai Affinity Biopharmaceutical
- Class Antibodies; Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 06 Aug 2024 Preclinical trials in Solid tumours in China (Parenteral) (Shanghai Affinity Biopharmaceutical pipeline, August 2024)